Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study
<p>Introduction: The potential for curative conversion with immunotherapy-based systemic treatment used with noncurative intent in patients with hepatocellular carcinoma (HCC) remains debated. This study aimed to provide a reliable epidemiological snapshot of response patterns to atezoliz...
Gardado en:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Karger Publishers
2026-01-01
|
| Series: | Liver Cancer |
| Acceso en liña: | https://karger.com/article/doi/10.1159/000547792 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
